Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Cited by Google
- Similars in SciELO
- Similars in Google
Share
Revista Colombiana de Nefrología
On-line version ISSN 2500-5006
Abstract
GARCIA OTERO, Gonzalo Agustín; ACEVES QUINTERO, Claudia Alejandra; CORONA MELENDEZ, Juan Carlos and AMAYA CARRENO, Marco Antonio. Cytomegalovirus colitis in kidney transplant recipients: presentation of two cases. Rev. colom. nefrol. [online]. 2020, vol.7, n.1, pp.113-120. Epub Dec 11, 2020. ISSN 2500-5006. https://doi.org/10.22265/acnef.7.1.338.
Cytomegalovirus infection is a latent risk among immunocompromised kidney transplant recipients and is associated with increased risk of allograft failure and death. CMV infection can manifest as active infection or as CMV disease (divided in CMV syndrome and CMV tissue-invasive disease). We present two cases of tissue invasive CMV disease, presenting within 7 months after kidney transplantation. Both cases were D+/R-, received lymphocyte-depleting agents and mycophenolate, and both received CMV prophylaxis according to General Practice Guidelines. CMV disease criteria included detectable viral replication in blood, classical endoscopic findings and histopathological confirmation. We emphasize the need of categorical identification of CMV infection risk factors among kidney transplantation recipients, specially CMV donor/recipient serostatus and immunosuppressive medication. Although clinical practice guidelines suggest 1 to 3 months CMV prophylaxis in high-risk cases, extended prophylaxis and immunosuppressive medication adjustment should be considered.
Keywords : Kidney transplantation; cytomegalovirus infections.